Resmed (RMD) Share-based Compensation (2009 - 2026)
Resmed's (RMD) quarterly Share-based Compensation came in at $26.8 million in Q1 2026, up 7260.44% YoY from $364000.0 in Q1 2025, and down 7.42% on a QoQ basis from $28.9 million in Q4 2025.
Resmed (RMD) Share-based Compensation (2009 - 2026) Analysis & Trends
Resmed (RMD) has 18 years of Share-based Compensation data on file, last reported at $26.8 million in Q1 2026.
- Quarterly Share-based Compensation rose 7260.44% year-over-year to $26.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.5 million (down 13.27% YoY) and the FY2025 annual result came in at $18.1 million, down 77.46% from the prior year.
- Share-based Compensation slipped to $26.8 million in Q1 2026, from $28.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $71.8 million in Q2 2024 to a low of -$30.0 million in Q1 2024.
- A 5-year average of $14.0 million and a median of $16.0 million in 2022 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 21411.38% in 2024, down 872.59% in 2024.
- Tracing RMD's Share-based Compensation over 5 years: stood at $16.5 million in 2022, then jumped by 131.57% to $38.1 million in 2023, then sank by 56.11% to $16.7 million in 2024, then soared by 72.93% to $28.9 million in 2025, then fell by 7.42% to $26.8 million in 2026.
- The last three Share-based Compensation figures came in at $26.8 million (Q1 2026), $28.9 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 45.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.46 Mn |
| Jun 30, 2026 | 27.46 Mn |
| Mar 31, 2026 | 26.79 Mn |
| Mar 31, 2026 | 26.79 Mn |
| Dec 31, 2025 | 28.94 Mn |
| Dec 31, 2025 | 28.94 Mn |
| Sep 30, 2025 | 21.16 Mn |
| Sep 30, 2025 | 21.16 Mn |
| Jun 30, 2025 | 590,000.00 |
| Jun 30, 2025 | 590,000.00 |
| Mar 31, 2025 | 364,000.00 |
| Mar 31, 2025 | 364,000.00 |
| Dec 31, 2024 | 16.73 Mn |
| Dec 31, 2024 | 16.73 Mn |
| Sep 30, 2024 | 389,000.00 |
| Sep 30, 2024 | 389,000.00 |
| Jun 30, 2024 | 71.85 Mn |
| Jun 30, 2024 | 71.85 Mn |
| Mar 31, 2024 | -30.01 Mn |
| Mar 31, 2024 | -30.01 Mn |